COST-EFFECTIVENESS ANALYSIS OF CANCER RISK REDUCTION STRATEGIES FOR BRCA MUTATION CARRIERS

Author(s)

Khodorovich OS1, Solodkiy VA1, Derkach EV2
1Russian Scientific Center of Roentgenoradiology, Moscow, Russia, 2The Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia

Women with BRCA mutations inherit high risks of breast and ovarian cancer; options to reduce cancer risk include preventive surgeries or regular breast screening. 

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCN152

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Oncology

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×